Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 285 | 2024 |
Bypassing protein corona issue on active targeting: zwitterionic coatings dictate specific interactions of targeting moieties and cell receptors R Safavi-Sohi, S Maghari, M Raoufi, SA Jalali, MJ Hajipour, ... ACS applied materials & interfaces 8 (35), 22808-22818, 2016 | 103 | 2016 |
Effect of cell sex on uptake of nanoparticles: the overlooked factor at the nanobio interface V Serpooshan, S Sheibani, P Pushparaj, M Wojcik, AY Jang, MR Santoso, ... ACS nano 12 (3), 2253-2266, 2018 | 95 | 2018 |
Disease-specific protein corona sensor arrays may have disease detection capacity G Caracciolo, R Safavi-Sohi, R Malekzadeh, H Poustchi, M Vasighi, ... Nanoscale Horizons 4 (5), 1063-1076, 2019 | 82 | 2019 |
An overview of nanoparticle protein corona literature MJ Hajipour, R Safavi‐Sohi, S Sharifi, N Mahmoud, AA Ashkarran, E Voke, ... Small 19 (36), 2301838, 2023 | 31 | 2023 |
4D-LQTA-QSAR and docking study on potent gram-negative specific LpxC inhibitors: a comparison to CoMFA modeling JB Ghasemi, R Safavi-Sohi, EG Barbosa Molecular diversity 16 (1), 203-213, 2012 | 30 | 2012 |
Identification of the proteins determining the blood circulation time of nanoparticles C Marques, MJ Hajipour, C Marets, A Oudot, R Safavi-Sohi, M Guillemin, ... ACS nano 17 (13), 12458-12470, 2023 | 16 | 2023 |
The possible role of sex as an important factor in development and administration of lipid nanomedicine-based COVID-19 vaccine E Vulpis, F Giulimondi, L Digiacomo, A Zingoni, R Safavi-Sohi, S Sharifi, ... Molecular Pharmaceutics 18 (6), 2448-2453, 2021 | 16 | 2021 |
Quasi 4D-QSAR and 3D-QSAR study of the pan class I phosphoinositide-3-kinase (PI3K) inhibitors R Safavi-Sohi, JB Ghasemi Medicinal Chemistry Research 22, 1587-1596, 2013 | 13 | 2013 |
Mixed 2D–3D-LQTA-QSAR study of a series of Plasmodium falciparum dUTPase inhibitors RA de Araújo Santos, CA Braz, JB Ghasemi, R Safavi-Sohi, EG Barbosa Medicinal Chemistry Research 24, 1098-1111, 2015 | 12 | 2015 |
4‐Methyl morpholinium bis‐(thio) barbiturates: Synthesis, structure, anticancer evaluation, and CoMFA study N Noroozi Pesyan, H Rashidnejad, MA Esmaeili, E Safari, T Tunç, ... Journal of the Chinese Chemical Society 67 (9), 1679-1695, 2020 | 11 | 2020 |
Synthesis, antibacterial activity, and CoMFA study of new 1, 2, 3-triazolyl 7-carboxamidodesacetoxy cephalosporanic acid derivatives M Mohebbi, P Salehi, M Bararjanian, A Aliahmadi, R Safavi-Sohi, ... Medicinal Chemistry Research 23, 4531-4541, 2014 | 9 | 2014 |
Correction: Disease-specific protein corona sensor arrays may have disease detection capacity G Caracciolo, R Safavi-Sohi, R Malekzadeh, H Poustchi, M Vasighi, ... Nanoscale Horizons 5 (2), 372-372, 2020 | 3 | 2020 |
Application of 3D-QSAR on a series of potent P38-MAP kinase inhibitors SR SAFAVI, JB Ghasemi Journal of Applied Chemical Research 7 (1), 64-74, 2013 | 2 | 2013 |
3D-QSAR and docking analysis on a series of multi-cyclin-dependent kinase inhibitors using CoMFA, and CoMSIA J B Ghasemi, M Ayati, S Pirhadi, R Safavi-Sohi Journal of the Iranian Chemical Research 4 (4), 235-249, 2011 | 1 | 2011 |
An Overview of Nanoparticle Protein Corona Literature (Small 36/2023) MJ Hajipour, R Safavi‐Sohi, S Sharifi, N Mahmoud, AA Ashkarran, E Voke, ... Small 19 (36), 2370293, 2023 | | 2023 |